Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells
Kalpana Tilekar, Neha Upadhyay, Markus Schweipert, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 154, pp. 105512-105512
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
Yi Zhang, Qiong Li, Zhao Huang, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4568-4568
Open Access | Times Cited: 83
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Ahmed A. B. Mohamed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Design, synthesis of new 2,4-thiazolidinediones: In-silico, in-vivo anti-diabetic and anti-inflammatory evaluation
Shankar Gharge, Shankar G. Alegaon, Shriram D. Ranade, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100151-100151
Open Access | Times Cited: 11
Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors
Yuxuan Wang, Zhiqiang Sun, Zean Zhao, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
Kalpana Tilekar, Neha Upadhyay, Cristina V. Iancu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188457-188457
Open Access | Times Cited: 58
Design, synthesis, characterization and Antidiabetic evaluation of 3,5-substituted thiazolidinediones: Evidenced by network pharmacology, Molecular docking, dynamic simulation, in vitro and in vivo assessment
Shankar Gharge, Shankar G. Alegaon, Swaroop Jadhav, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100213-100213
Open Access | Times Cited: 8
Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
Lamya H. Al-Wahaibi, Amer A. Amer, Adel A. Marzouk, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 399-399
Open Access | Times Cited: 41
Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery
Kalpana Tilekar, Onkar Shelke, Neha Upadhyay, et al.
Journal of Molecular Structure (2021) Vol. 1250, pp. 131767-131767
Closed Access | Times Cited: 35
Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4
Zhongzhen Zeng, Qing Nian, Nianzhi Chen, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112086-112086
Open Access | Times Cited: 35
Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives
Zhuoya Yu, Xiangxiang Zhou, Xin Wang
Cancer Research (2022) Vol. 82, Iss. 17, pp. 2955-2963
Open Access | Times Cited: 23
The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review
Kumari Kajal, Gurpreet Singh, Tathagata Pradhan, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 20
Chemistry and Applications of Functionalized 2,4‐Thiazolidinediones
Ayman M. Ibrahim, Mai E. Shoman, Mamdouh F. A. Mohamed, et al.
European Journal of Organic Chemistry (2023) Vol. 26, Iss. 19
Closed Access | Times Cited: 12
Thiazolidinedione derivatives: emerging role in cancer therapy
Ganesh Latambale, Kapil Juvale
Molecular Diversity (2025)
Closed Access
Novel 3-aroyl-5-arylidene-1,3-thiazolidine-2,4-diones: synthesis and antitumor activity
Xia Zhang, Pingping Fan, Shouzuo Wei, et al.
Mendeleev Communications (2025) Vol. 35, Iss. 2, pp. 155-157
Closed Access
Antifungal Thiazolidines: Synthesis and Biological Evaluation of Mycosidine Congeners
I. B. Levshin, Alexander Y. Simonov, Sergey N. Lavrenov, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 563-563
Open Access | Times Cited: 17
Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR‐γ agonists and thymidylate synthase inhibitors
Syed Nazreen
Archiv der Pharmazie (2021) Vol. 354, Iss. 9
Closed Access | Times Cited: 21
GLUT3 inhibitor discovery through in silico ligand screening and in vivo validation in eukaryotic expression systems
Cristina V. Iancu, Giovanni Bocci, Mohd Ishtikhar, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Design, Synthesis, and Characterization of Novel Thiazolidine-2,4-Dione-Acridine Hybrids as Antitumor Agents
Monika Garberová, Z Kudlicková, Radka Michalková, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3387-3387
Open Access | Times Cited: 2
Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
Mayavan Viji, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024), pp. 140529-140529
Closed Access | Times Cited: 2
Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies
Chenyu Zha, Xinyu Yang, Jun Yang, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 2
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks
Neha Upadhyay, Kalpana Tilekar, Sabreena Safuan, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 9, pp. 1540-1554
Open Access | Times Cited: 15
Cardiac glycosides stimulate endocytosis of GLUT1 via intracellular Na+,K+‐ATPase α3‐isoform in human cancer cells
Takuto Fujii, Mizuki Katoh, Manami Ootsubo, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2980-2991
Closed Access | Times Cited: 11
SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
Yanli Zhang, Qin Han, Jing Bian, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements
Sneha Gupta, Sumeet Jha, Supriya Rani, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
Novel benzothiazole/benzothiazole thiazolidine‐2,4‐dione derivatives as potential FOXM1 inhibitors: In silico, synthesis, and in vitro studies
Khaled A. N. Abusharkh, Ferah Cömert Önder, Venhar Çınar, et al.
Archiv der Pharmazie (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top